137 related articles for article (PubMed ID: 24948079)
1. Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice.
Einat H
Pharmacol Rep; 2014 Aug; 66(4):722-5. PubMed ID: 24948079
[TBL] [Abstract][Full Text] [Related]
2. Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in black Swiss mice.
Kara NZ; Flaisher-Grinberg S; Einat H
Pharmacol Rep; 2015 Oct; 67(5):928-33. PubMed ID: 26398387
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania.
Flaisher-Grinberg S; Overgaard S; Einat H
J Neurosci Methods; 2009 Feb; 177(1):44-50. PubMed ID: 18930764
[TBL] [Abstract][Full Text] [Related]
4. The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors.
Ene HM; Kara NZ; Einat H
Behav Pharmacol; 2015 Jun; 26(4):331-7. PubMed ID: 25590966
[TBL] [Abstract][Full Text] [Related]
5. Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder.
Dencker D; Husum H
Behav Brain Res; 2010 Feb; 207(1):78-83. PubMed ID: 19815032
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
Abrial E; Bétourné A; Etiévant A; Lucas G; Scarna H; Lambás-Señas L; Haddjeri N
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25577667
[TBL] [Abstract][Full Text] [Related]
7. The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs.
Sabioni P; Baretta IP; Ninomiya EM; Gustafson L; Rodrigues AL; Andreatini R
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1927-31. PubMed ID: 18930105
[TBL] [Abstract][Full Text] [Related]
8. Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Kalinichev M; Dawson LA
Int J Neuropsychopharmacol; 2011 Sep; 14(8):1051-67. PubMed ID: 21208504
[TBL] [Abstract][Full Text] [Related]
9. Questioning the predictive validity of the amphetamine-induced hyperactivity model for screening mood stabilizing drugs.
Lan A; Einat H
Behav Brain Res; 2019 Apr; 362():109-113. PubMed ID: 30630015
[TBL] [Abstract][Full Text] [Related]
10. Introducing Female Black Swiss Mice: Minimal Effects of Sex in a Strain-Specific Battery of Tests for Mania-Like Behavior and Response to Lithium.
Ene HM; Kara NZ; Einat H
Pharmacology; 2015; 95(5-6):224-8. PubMed ID: 25924800
[TBL] [Abstract][Full Text] [Related]
11. Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine.
Flaisher-Grinberg S; Einat H
Front Psychiatry; 2010; 1():10. PubMed ID: 21423422
[TBL] [Abstract][Full Text] [Related]
12. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior.
Flaisher-Grinberg S; Einat H
J Pharmacol Toxicol Methods; 2009; 59(3):141-5. PubMed ID: 19341808
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder.
Einat H; Yuan P; Szabo ST; Dogra S; Manji HK
Neuropsychobiology; 2007; 55(3-4):123-31. PubMed ID: 17641532
[TBL] [Abstract][Full Text] [Related]
14. Behavioral differences in black Swiss mice from separate colonies: implications for modeling domains of mania.
Juetten J; Einat H
Behav Pharmacol; 2012 Apr; 23(2):211-4. PubMed ID: 22193594
[TBL] [Abstract][Full Text] [Related]
15. Proposing the sweet solution preference test as a screening assay for anti-manic effects of mood stabilizers.
Kara N; Flaisher-Grinberg S; Einat H
J Neurosci Methods; 2020 Dec; 346():108920. PubMed ID: 32937157
[TBL] [Abstract][Full Text] [Related]
16. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?
Pereira M; Andreatini R; Schwarting RK; Brenes JC
Psychopharmacology (Berl); 2014 Jul; 231(13):2567-77. PubMed ID: 24414610
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with mood stabilizer lithium inhibits amphetamine-induced risk-taking manic-like behaviors.
Zhou Z; Wang Y; Tan H; Bharti V; Che Y; Wang JF
Neurosci Lett; 2015 Aug; 603():84-8. PubMed ID: 26219985
[TBL] [Abstract][Full Text] [Related]
19. Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
Redrobe JP; Nielsen AN
Behav Brain Res; 2009 Mar; 198(2):481-5. PubMed ID: 19162078
[TBL] [Abstract][Full Text] [Related]
20. Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.
Cechinel-Recco K; Valvassori SS; Varela RB; Resende WR; Arent CO; Vitto MF; Luz G; de Souza CT; Quevedo J
J Psychopharmacol; 2012 Dec; 26(12):1594-604. PubMed ID: 23076832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
